Category: Intellectual property
-
European Patent Office to Translate Patents with Google Tech
The European Patent Office (EPO), headquarted in Munich, Germany and Google signed an agreement to collaborate on machine translation of patents into 32 European and Asian languages. The signing follows a November agreement between EPO and Google to pursue the deal. EPO will use Google’s technology to offer translation of patents on its Web site…
-
Patent Awarded for Protein Biomarker Cancer Screening
Van Andel Research Institute (VARI), a biomedical research institute in Grand Rapids, Michigan, and Gentel Biosciences, a biotechnology company in Madison, Wisconsin received a patent for their process to profile changes in proteins binding to antibodies in test arrays. This process can screen for biomarkers indicating early stages of cancer, including liver and pancreatic cancers…
-
Company Licenses Ultrasound Atherosclerosis Therapy
International Cardio Corporation (ICC) in Excelsior, Minnesota has licensed technology developed at University of Minnesota to treat atherosclerosis with ultrasound. The ultrasound treatment is considered less invasive and potentially safer for the patient than current therapies, such as stents and balloon angioplasty. Atherosclerosis is the name of the process in which deposits of fatty substances,…
-
University Patents Peptide-Based Adhesive
The technology transfer arm of Kansas State University in Manhattan has received an international patent for an adhesive that increases in strength as moisture is removed. The patent covers an adhesive made from peptides — a compound containing two or more amino acids that link together. The adhesive was created by biochemistry professor John Tomich…
-
FDA Approves Improved Laser Eye Surgery Technology
The U.S. Food and Drug Administration approved an enhanced technology for refractive (laser) eye surgery, based on research conducted at University of Rochester in New York. The Rochester Nomogram, as the technology is called, is licensed to Technolas Perfect Vision, a cataract and refractive laser company formed through a joint venture of lens manufacturer Bausch…
-
U.K. Company Licenses Harvard Graphene DNA Technology
Oxford Nanopore Technologies Ltd. in Oxford, U.K. said today it signed a licensing agreement with Harvard University to commercialize graphene technology from Harvard’s labs for DNA sequencing. The company already has a deal with Harvard’s technology transfer office to develop basic sensing methods through solid-state nanopores. Graphene is a robust, single-atom thick lattice of carbon…
-
Ultrasound System Developed for Submarine Data, Power
An engineering doctoral student at Rensselaer Polytechnic Institute in Troy, New York has developed a new system using ultrasound to transmit large quantities of data and power wirelessly through thick metal walls, like the hulls of ships and submarines. The system built and demonstrated by Tristan Lawry (pictured right) is one of three finalists for…
-
Profs Develop, Patent Device to Encourage Senior Exercise
Nursing and engineering faculty at University of Rhode Island in Kingston developed a device to send friendly reminders to older people that they need to get more exercise. In November, the university patented this system that analyzes activity levels of senior citizens and generates audio reminder messages in familiar voices. The original idea for the…
-
Universities License Regenerative Membrane Technology
The technology transfer offices at Hebrew University of Jerusalem and Hadassah University Medical Center in Israel, say they have licensed technology for regenerative membrane implants developed at their institutions. RegeneCure, the licensee — also in Jerusalem — will further develop and commercialize the technology for bone tissue engineering in trauma, spine, and reconstructive cranial and…
-
Tufts University Gets Patent for Kidney Disease Treatment
Researchers at Tufts University’s veterinary school in Grafton, Massachusetts have received a U.S. patent for an antibody-based treatment for hemolytic uremic syndrome (HUS), a potentially fatal outcome of E. coli poisoning and a leading cause of kidney failure in children. The Tufts technology covered by the patent, developed by microbiology professor Saul Tzipori, uses human…